Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

10.1200/JCO.2017.77.0388

Saved in:

Bibliographic Details
Main Authors:	Ma, Brigette BY, Lim, Wan-Teck, Goh, Boon-Cher, Hui, Edwin P, Lo, Kwok-Wai, Pettinger, Adam, Foster, Nathan R, Riess, Jonathan W, Agulnik, Mark, Chang, Alex YC, Chopra, Akhil, Kish, Julie A, Chung, Christine H, Adkins, Douglas R, Cullen, Kevin J, Gitlitz, Barbara J, Lim, Dean W, To, Ka-Fai, Chan, KC Allen, Lo, YM Dennis, King, Ann D, Erlichman, Charles, Yin, Jun, Costello, Brian A, Chan, Anthony TC
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	AMER SOC CLINICAL ONCOLOGY 2024
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology BARR-VIRUS DNA PD-L1 EXPRESSION CELL CARCINOMA THERAPY CANCER MELANOMA MUTATIONS BLOCKADE ESCAPE SUBSET
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/248960
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items